Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Kahraman, Seda; Erul, Enes; Gumusay, Ozge; Guven, Deniz Can; Aksoy, Sercan; Basaran, Gul; Seyyar, Mustafa; Sahin, Elif; Cabuk, Devrim; Bayram, Ertugrul; Paydas, Semra; Demirel, Burcin Cakan; Yaren, Arzu; Gulbagci, Burcu; Hacibekiroglu, Ilhan; Baytemur, Naziyet Kose; Demirci, Umut; Davarci, Sena Ece; Demir, Hacer; Mocan, Eda Eylemer; Dogan, Ozlem; Cilbir, Ebru; Yasar, Alper; Bayoglu, Ibrahim Vedat; Hizal, Mutlu; Kayikcioglu, Erkan; Cetin, Bulent; Acar, Omer; Erdogan, Atike Pinar; Keskinkilic, Merve; Yavuzsen, Tugba; Unal, Olcun Umit; Yilmaz, Funda; Dogan, Mutlu; Orhan, Sibel Oyucu; Cubukcu, Erdem; Erol, Cihan; Sakalar, Teoman; Dulgar, Ozgecan; Karakas, Yusuf; Ozkanli, Gulhan; Duman, Berna Bozkurt; Isik, Deniz; Karaoglanoglu, Muge; Okutur, Sadi Kerem; Yildirim, Nilgun; Aydin, Esra; Uluc, Basak Oyan; Keser, Murat; Bilgin, Burak; Aksoy, Asude; Eren, Onder; Kalkan, Nurhan Onal; Er, Muhammed Muhiddin; Yucel, Hakan; Sunar, Veli; Paksoy, Nail; Aydin, Dincer; Turhal, Nazim Serdar; Menekse, Serkan; Kut, Engin; Aykan, Musa Baris; Ozdemir, Ozlem; Ozcelik, Melike; Iriagac, Yakup; Selcukbiricik, Fatih; Inal, Ali; Karadurmus, Nuri; Akinci, Muhammed Bulent; Sendur, Mehmet Ali Nahit

doi:10.1016/j.clbc.2025.03.003

Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Date

2025

Authors

dc.identifier.doi

10.1016/j.clbc.2025.03.003

dc.identifier.other

WOS:001513877300025

Publisher

CIG MEDIA GROUP, LP

DOI

10.1016/j.clbc.2025.03.003

Keywords

CDK 4 , 6 inhibitors , Fulvestrant , HR\\-positive , Metastatic breast cancer , Real\\-world data

URI

https://openaccess.acibadem.edu.tr/handle/11443/4926

Collections

WOS

Full item page

Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By